Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2024 Jun;21(6):356.
doi: 10.1038/s41569-024-01033-x.

The coronary sinus reducer improves angina symptoms in patients with stable CAD

Affiliations
Comment

The coronary sinus reducer improves angina symptoms in patients with stable CAD

Karina Huynh. Nat Rev Cardiol. 2024 Jun.
No abstract available

PubMed Disclaimer

Comment on

  • Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trial.
    Foley MJ, Rajkumar CA, Ahmed-Jushuf F, Simader FA, Chotai S, Pathimagaraj RH, Mohsin M, Salih A, Wang D, Dixit P, Davies JR, Keeble TR, Cosgrove C, Spratt JC, O'Kane PD, De Silva R, Hill JM, Nijjer SS, Sen S, Petraco R, Mikhail GW, Khamis R, Kotecha T, Harrell FE, Kellman P, Francis DP, Howard JP, Cole GD, Shun-Shin MJ, Al-Lamee RK. Foley MJ, et al. Lancet. 2024 Apr 20;403(10436):1543-1553. doi: 10.1016/S0140-6736(24)00256-3. Epub 2024 Apr 8. Lancet. 2024. PMID: 38604209 Clinical Trial.

References

Original article
    1. Foley, M. J. et al. Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trial. Lancet https://doi.org/10.1016/S0140-6736(24)00256-3 (2024) - DOI - PubMed

LinkOut - more resources